Company
ChinaChinese Peptide Company, Hangzhou, China – FDA Inspections
Inspection records and compliance data for Chinese Peptide Company in Hangzhou. 5 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected September 04, 2026.
Company Profile
This profile covers Chinese Peptide Company based in Hangzhou, China.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 1
First inspected February 16, 2012. Last inspected September 4, 2026.
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 4, 2026 | Not classified | Human Drugs | 1339684 |
| June 14, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1242852 |
| March 17, 2016 | NAI | Medical Devices & Rad Health · Compliance: Devices | 967430 |
| November 14, 2014 | NAI | Human Drugs · Drug Quality Assurance | 908354 |
| February 16, 2012 | NAI | Human Drugs · Drug Quality Assurance | 774762 |
FDA documents
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Biogen MA Inc.
Bachem Americas, Inc.
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
Shandong Anshun Pharmaceutical Co., Ltd.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.
Catalent Pharma Solutions, LLC
Scientific Protein Laboratories, LLC
Ajinomoto Bio-Pharma Services India Private Limited
Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)
Cytovance Biologics Inc.
Company Information
Name
Chinese Peptide Company
FEI Number
3004518843
Address
Hangzhou Economic, No. 69 12th Street; And Technological Development Zone, Hangzhou, China
Country
China
ID: ba8c6a32-f679-405b-bb0a-e82713b7cb62